Detalhe da pesquisa
1.
Clinical Pharmacokinetics of the Androgen Receptor Inhibitor Darolutamide in Healthy Subjects and Patients with Hepatic or Renal Impairment.
Clin Pharmacokinet
; 61(4): 565-575, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34866168
2.
A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma.
Cancer Chemother Pharmacol
; 89(6): 825-831, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322287
3.
Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors.
Clin Cancer Res
; 27(10): 2723-2733, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33622704
4.
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
Target Oncol
; 15(6): 803, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108585
5.
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
Target Oncol
; 15(2): 163-174, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314268
6.
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.
Mol Cancer Ther
; 19(2): 468-478, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31619463
7.
Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers.
Cancer Chemother Pharmacol
; 80(3): 535-544, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28714036
8.
Thoracic empyema after pneumonectomy: intrathoracic application of vacuum-assisted closure therapy.
Ann Thorac Surg
; 89(2): 603-4, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20103353